€57,48 €47,50 excl. VAT
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle.
10 working days
From €5,95 shipping and administration per order (incl. VAT)
Specifications
| Breeds | |
|---|---|
| Gene | |
| Organ | |
| specimen | Hair, Blood EDTA, Blood Heparin, Semen, Tissue |
| Mode of Inheritance | |
| Chromosome | |
| Also known as | |
| Year Published |
General information
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle. The disease caused by mutations in the ryanodine receptor type 1 (RyR1) gene. The RyR1 gene causes dysfuntion of the calcium release channel of the sarcoplasmic reticulum in skeletal muscle.
Clinical features
Clinical feautures are intense heat, hypercapnia, lactic acidosis, and, in many cases, death.
Additional information
It is still unknown if the mutation in the RyR1 gene is responsible for all cases of MH in horses.
References
Pubmed ID: 15318347
Omia ID: 621